Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we ...
Should You Buy the Dip in Novo Nordisk Stock Right Now?
Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a year. I think now is a terrific opportunity to scoop up shares of Novo on the ...
Reuters14d
'A worst case scenario for Novo': Read the market reaction to CagriSema trial
LONDON, Dec 20 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Friday its ... "The results are a worst-case ...
Stocktwits on MSN14d
Novo Nordisk Heads For Worst Day In 22 Years As New Obesity Drug Underwhelms: Retail Brushes Off ‘Super Silly’ Drop
Novo Nordisk shares plunged 18% Friday afternoon and were headed for their worst intraday drop since April 2002. However, ...